Clodagh Keohane

2.2k total citations
15 papers, 254 citations indexed

About

Clodagh Keohane is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Clodagh Keohane has authored 15 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 11 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Clodagh Keohane's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Kruppel-like factors research (7 papers) and Eosinophilic Disorders and Syndromes (5 papers). Clodagh Keohane is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Kruppel-like factors research (7 papers) and Eosinophilic Disorders and Syndromes (5 papers). Clodagh Keohane collaborates with scholars based in United Kingdom, Ireland and United States. Clodagh Keohane's co-authors include Claire Harrison, Mary Frances McMullin, Bridget S. Wilkins, Pilar Perez Abellan, Shahram Kordasti, Ghulam J. Mufti, Thomas Seidl, Donal P. McLornan, Ruben A. Mesa and Jason Gotlib and has published in prestigious journals such as Blood, BMJ and British Journal of Haematology.

In The Last Decade

Clodagh Keohane

11 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clodagh Keohane United Kingdom 8 182 157 83 73 25 15 254
Sabrina Caberlon Italy 8 264 1.5× 218 1.4× 156 1.9× 110 1.5× 12 0.5× 12 349
R. Hehlmann Germany 8 194 1.1× 212 1.4× 83 1.0× 111 1.5× 14 0.6× 20 308
Gioia Colafigli Italy 11 178 1.0× 270 1.7× 99 1.2× 61 0.8× 17 0.7× 41 333
Cristina Bucelli Italy 9 162 0.9× 173 1.1× 81 1.0× 73 1.0× 9 0.4× 33 250
Eun‐Jung Jang South Korea 10 109 0.6× 130 0.8× 16 0.2× 66 0.9× 14 0.6× 26 202
Chandrakala Shanmukhaiah India 11 140 0.8× 228 1.5× 93 1.1× 25 0.3× 12 0.5× 53 319
Daniella Kerbauy United States 4 147 0.8× 226 1.4× 89 1.1× 58 0.8× 32 1.3× 7 277
Giuseppe Auteri Italy 7 63 0.3× 87 0.6× 52 0.6× 33 0.5× 22 0.9× 22 143
Elisa Zuffa Italy 8 214 1.2× 212 1.4× 106 1.3× 92 1.3× 7 0.3× 26 313
Amir T. Fathi United States 7 95 0.5× 175 1.1× 73 0.9× 20 0.3× 22 0.9× 24 233

Countries citing papers authored by Clodagh Keohane

Since Specialization
Citations

This map shows the geographic impact of Clodagh Keohane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clodagh Keohane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clodagh Keohane more than expected).

Fields of papers citing papers by Clodagh Keohane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clodagh Keohane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clodagh Keohane. The network helps show where Clodagh Keohane may publish in the future.

Co-authorship network of co-authors of Clodagh Keohane

This figure shows the co-authorship network connecting the top 25 collaborators of Clodagh Keohane. A scholar is included among the top collaborators of Clodagh Keohane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clodagh Keohane. Clodagh Keohane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Hayes, Brian, et al.. (2021). High grade non-germinal centre-like diffuse large B-cell lymphoma double expressor presenting as a hydrocoele. BMJ Case Reports. 14(12). e247381–e247381.
3.
Desterro, Joana, Donal P. McLornan, Natalia Curto‐García, et al.. (2019). Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience. British Journal of Haematology. 186(4). 561–564. 7 indexed citations
4.
5.
Keohane, Clodagh, Shahram Kordasti, Thomas Seidl, et al.. (2015). JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells. British Journal of Haematology. 171(1). 60–73. 68 indexed citations
6.
Keohane, Clodagh, et al.. (2013). The diagnosis and management of erythrocytosis. BMJ. 347(nov18 1). f6667–f6667. 51 indexed citations
7.
Harrison, Claire, et al.. (2013). Treatment and management of myelofibrosis in the era of JAK inhibitors. Biologics. 7. 189–189. 9 indexed citations
8.
Wilkins, Bridget S., et al.. (2013). Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib. Haematologica. 98(12). 1872–1876. 58 indexed citations
9.
Harrison, Claire, Ruben A. Mesa, David M. Ross, et al.. (2013). Practical management of patients with myelofibrosis receiving ruxolitinib. Expert Review of Hematology. 6(5). 511–523. 25 indexed citations
10.
11.
Keohane, Clodagh, Ruben A. Mesa, & Claire Harrison. (2013). The Role of JAK1/2 Inhibitors in the Treatment of Chronic Myeloproliferative Neoplasms. American Society of Clinical Oncology Educational Book. 301–305.
12.
Keohane, Clodagh, Ruben A. Mesa, & Claire Harrison. (2013). The Role of JAK1/2 Inhibitors in the Treatment of Chronic Myeloproliferative Neoplasms. American Society of Clinical Oncology Educational Book. 33. 301–305. 3 indexed citations
13.
Harrison, Claire & Clodagh Keohane. (2013). Myeloproliferative neoplasms. Medicine. 41(5). 265–268. 1 indexed citations
14.
Keohane, Clodagh & Claire Harrison. (2012). Essential thrombocythemia: new advances in an old disease. Clinical Investigation. 2(6). 603–614. 1 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabrina Caberlon Breakdown of academic impact, for papers by R. Hehlmann Breakdown of academic impact, for papers by Gioia Colafigli Breakdown of academic impact, for papers by Cristina Bucelli Breakdown of academic impact, for papers by Eun‐Jung Jang Breakdown of academic impact, for papers by Chandrakala Shanmukhaiah Breakdown of academic impact, for papers by Daniella Kerbauy Breakdown of academic impact, for papers by Giuseppe Auteri Breakdown of academic impact, for papers by Elisa Zuffa Breakdown of academic impact, for papers by Amir T. Fathi
Rankless by CCL
2026